Wed, December 1, 2021

Graig Suvannavejh Maintained (TGTX) at Strong Sell with Decreased Target to $13 on, Dec 1st, 2021

Graig Suvannavejh of Goldman Sachs, Maintained "TG Therapeutics, Inc." (TGTX) at Strong Sell with Decreased Target from $26 to $13 on, Dec 1st, 2021.

Graig, nor any peers, have made any analyst calls on TGTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30